GSK8573
GSK8573 is an inactive control compound for GSK2801 (acetyl-lysine competitive inhibitor of BAZ2A and BAZ2B bromodomains) . GSK8573 has binding activity to BRD9 with a Kd value of 1.04 μM and is inactive against BAZ2A/B and other bromodomain familiy. GSK8573 can be used as a structurally related negative control compound in biological experiments[1].
Product Specifications
CAS Number
1693766-04-9
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gsk8573.html
Concentration
10mM
Purity
99.53
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
CC(C1=CC(C2=CC=CC(OC)=C2)=C3C=C(OCCC)C=CN13)=O
Molecular Formula
C20H21NO3
Molecular Weight
323.39
Precautions
H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD9
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![TCP10L3 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2C2]](https://cdn.genprice.uk/products/937/6868c3f3994c49e6dc40266d/imageurl/ta809068am.webp)
TCP10L3 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2C2]
![DPPA5 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI2F6]](https://cdn.genprice.uk/products/937/6868c409994c49e6dc404bd1/imageurl/ta810842bm.webp)
DPPA5 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI2F6]
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2784), CF405S conjugate, 0.1mg/mL
![Ethyl 4-(8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate](https://cdn.genprice.uk/products/572/7541526847014/imageurl/trc-e902775-25mg.webp)
Ethyl 4-(8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
